Bianca Weinstock-Guttman, Katelyn Kavak, Caila Vaughn, et al. Discontinuation of disease modifying therapies in stable MS patients is associated with disability progression regardless of age. AAN 2018, S8.008.
‘Antisense’-oligonucleotide HTTRx verlaagt concentratie gemuteerd huntingtine
sep 2019 | Bewegingsstoornissen